Applied Optoelectronics looks undervalued if its capacity converts into the modeled revenue ramp. From disclosed capacity, quarterly revenue could rise from $858M in Q1 2027 to $1.89B in Q4 and $2.14B in Q1 2028, against a $6.8B market cap. A $7.5B annualized exit rate in 2027 at 40% gross margins would make an unchanged valuation surprising. Lumentum's capacity agreements into 2030-31 suggest demand may last beyond 2027-28, but execution risk remains. x.com 

Applied Optoelectronics' projected $5.65 billion in 2027 revenue against a $6 billion market cap drives its appeal. It may be the best opportunity in the market right now. x.com 

Applied Optoelectronics' Q3 and Q4 would have to be heroic to hit guidance, so a miss could still kill the stock. It trades below projected 2027 sales and much of the risk is already priced in, but that would not eliminate the downside on a miss. x.com 

Ongoing demand makes Applied Optoelectronics' risk/reward make a ton of sense at current levels. The price makes little sense if management is credible even a shred; execution could falter, but that risk is, without a doubt, already priced in. x.com 

Applied Optoelectronics' risk-reward is quite favorable because even a fraction of management's revenue goal would make the stock worth more. Management says monthly revenue in 2027 will match annual revenue in 2025; meeting that goal would put shares above $200. AAOI is a high-risk speculative stock, not a core holding or in Broadcom's league. Management is serviceable, not elite; those without high risk tolerance should avoid it. x.com 

Applied Optoelectronics' roughly $12B valuation is absurd any way you look at it, even after management raised its mid-2027 projection to $471M in monthly revenue. It doesn't hold up on 2027 revenue, let alone earnings or the margin compression co-packaged optics would bring. Management will keep overpromising and underdelivering, could face legal trouble over what looks like a pump and dump, and has been in such trouble before; its own employees deride the company. x.com  x.com  x.com 

Unusual call buying in Applied Optoelectronics is starting to make sense with shares at $81.50. The New Money App reported $80,000 of $99 calls expiring November 6, 2026, and $290,000 of $340 calls expiring January 21, 2028. x.com 

Applied Optoelectronics should trade above $150, in part because Lumentum's CEO says its optical components are sold out through early 2029 and it cannot meet roughly 70% of demand for some products through 2027. That industry signal strengthens the case for AAOI's expanding 800G/1.6T offerings after completion of its $600M ATM, with shares around $110. x.com 

Applied Optoelectronics is now an execution story with almost no room for error, not a demand story. Its ~$1.1B 2026 target needs Q4 revenue near $484M, up 78% on Q3 guidance, and 2026 operating profit looks closer to $59M than the $140M+ target management didn't repeat. Q2's profit came from a tax benefit. Shares are up 43.7% y/y on ATM sales, DSP and TIA shortages cap 1.6T, and the top 10 customers are 99% of revenue. Q4 near $380-400M would push the whole 2027 model out. x.com 

Applied Optoelectronics' laser capacity could be worth much more if Marvell pays over $100B for Lumentum. That price would show how valuable laser capacity is and, in that scenario, AAOI could reach $200 within a quarter or two. The deal is only a rumor, and its price is unknown. x.com